SciELO - Scientific Electronic Library Online

 
vol.24 issue4Global survival and biochemical relapse-free survival in patients with prostate cancer treated with intensity modulated radiotherapy (IMRT) at the National Cancer InstituteNeoantigen vaccines and cancer control: perspectives author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Cancerología

Print version ISSN 0123-9015

Abstract

MONTEALEGRE-PAEZ, Ana Lorena et al. Liquid biopsy in the diagnosis and monitoring of cancer patients: opportunities and challenges in Latin America. rev.colomb.cancerol. [online]. 2020, vol.24, n.4, pp.151-164.  Epub Mar 29, 2021. ISSN 0123-9015.  https://doi.org/10.35509/01239015.44.

In recent years, the study of circulating nucleic acids has made great progress in the field of oncology, allowing for significant advances in clinical applications of liquid biopsy in diverse areas such as prognosis, staging, recurrence prediction, selection and monitoring of treatments, among others. This advance is largely due to the development of new and better technologies, some of which have even been validated for the diagnosis and clinical follow-up of certain types of cancer. However, the use of liquid biopsy as an additional tool in clinical oncology remains under study. Given the worldwide importance of this technological advance, a literature review was conducted to establish the current status of the use of liquid biopsy in oncology, as well as its current clinical applications, with a particular focus on Latin America.

Keywords : Liquid biopsy; Latin America; Cell-Free Nucleic Acids; Molecular Targeted Therapy..

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )